The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Biophysics of cell membrane lipids in cancer drug resistance: Implications for drug transport and drug delivery with nanoparticles
Open accessAbstract
In this review, we focus on the biophysics of cell membrane lipids, particularly when cancers develop acquired drug resistance, and how biophysical changes in resistant cell membrane influence drug transport and nanoparticle-mediated drug delivery. Recent advances in membrane lipid research show the varied roles of lipids in regulating membrane P-glycoprotein function, membrane trafficking, apoptotic pathways, drug transport, and endocytic functions, particularly endocytosis, the primary mechanism of cellular uptake of nanoparticle-based drug delivery systems. Since acquired drug resistance alters lipid biosynthesis, understanding the role of lipids in cell membrane biophysics and its effect on drug transport is critical for developing effective therapeutic and drug delivery approaches to overcoming drug resistance. Here we discuss novel strategies for (a) modulating the biophysical properties of membrane lipids of resistant cells to facilitate drug transport and regain endocytic function and (b) developing effective nanoparticles based on their biophysical interactions with membrane lipids to enhance drug delivery and overcome drug resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional rafts in cell membranes
Simons, K., & Ikonen, E. (1997) · Nature · doi:10.1038/42408 · Cited by 9,757 · cited 1×
“Lipid rafts exist in the liquid-ordered phase state and are rich in cholesterol and sphingolipids [81].”
BackgroundTargeting multidrug resistance in cancer
Szakács, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1984 · Cited by 3,609
Mechanisms of Cancer Drug Resistance
Gottesman, M. M. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103929 · Cited by 2,643
Local force and geometry sensing regulate cell functions
Vogel, V., & Sheetz, M. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1890 · Cited by 2,328 · cited 1×
“For example, increases in local concentration of lipids that prefer formation of nonbilayer structures could influence membrane curvature, fusion, and fission events critical in endocytosis and exocytic processes [120].”
BackgroundMembrane curvature and mechanisms of dynamic cell membrane remodelling
McMahon, H. T., & Gallop, J. L. (2005) · Nature · doi:10.1038/nature04396 · Cited by 2,163
Lipid polymorphism and the functional roles of lipids in biological membranes
Cullis, P. R., & De Kruijff, B. (1979) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(79)90012-1 · Cited by 1,864
Physical principles of membrane organization
Israelachvili, J. N., Marčelja, S., & Horn, R. G. (1980) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583500001645 · Cited by 1,404
Batrakova, E. V., & Kabanov, A. V. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.04.013 · Cited by 1,278
When mutants gain new powers: News from the mutant p53 field
Brosh, R., & Rotter, V. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2693 · Cited by 1,132
Promoting apoptosis as a strategy for cancer drug discovery
Fesik, S. W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1736 · Cited by 1,098
Emerging roles for lipids in shaping membrane-protein function
Phillips, R., Ursell, T., Wiggins, P., & Sens, P. (2009) · Nature · doi:10.1038/nature08147 · Cited by 984
The Ceramide-centric Universe of Lipid-mediated Cell Regulation: Stress Encounters of the Lipid Kind
Hannun, Y. A., & Obeid, L. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r200008200 · Cited by 907
Nanoparticle-based combination therapy toward overcoming drug resistance in cancer
Hu, C.-M. J., & Zhang, L. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.01.008 · Cited by 686
Chen, A. M., Zhang, M., Wei, D., Stueber, D., Taratula, O., Minko, T., & He, H. (2009) · Small · doi:10.1002/smll.200900621 · Cited by 671
ABC Efflux Pump-Based Resistance to Chemotherapy Drugs
Eckford, P. D. W., & Sharom, F. J. (2009) · Chemical Reviews · doi:10.1021/cr9000226 · Cited by 597
Peetla, C., Stine, A., & Labhasetwar, V. (2009) · Molecular Pharmaceutics · doi:10.1021/mp9000662 · Cited by 559
Self-citationThe genetic origin of drug resistance in neoplasms: implications for systemic therapy.
Goldie, J. H., & Coldman, A. J. (1984) · PubMed · Cited by 511
Multidrug Resistance: Retrospect and Prospects in Anti-Cancer Drug Treatment
Perez-Tomas, R. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706777585077 · Cited by 509
Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance
Shapira, A., Livney, Y. D., Broxterman, H. J., & Assaraf, Y. G. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.01.003 · Cited by 504
Chain length-specific properties of ceramides
Grösch, S., Schiffmann, S., & Geisslinger, G. (2012) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.11.001 · Cited by 483
Sphingolipid organization in biomembranes: what physical studies of model membranes reveal
Brown, R. E. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.1.1 · Cited by 479
Increased exposure of anionic phospholipids on the surface of tumor blood vessels.
Ran, S., Downes, A., & Thorpe, P. E. (2002) · PubMed · Cited by 471
Crystal structure of the multidrug transporter P-glycoprotein from Caenorhabditis elegans
Jin, M. S., Oldham, M. L., Zhang, Q., & Chen, J. (2012) · Nature · doi:10.1038/nature11448 · Cited by 465
Membranes: A meeting point for lipids, proteins and therapies
Escribá, P. V., González‐Ros, J. M., Goñi, F. M., Kinnunen, P. K. J., Vigh, L., Sánchez‐Magraner, L., Fernández, A. M., Busquets, X., Horváth, I., & Barceló‐Coblijn, G. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00281.x · Cited by 454
Compartmentalization of ceramide signaling: physical foundations and biological effects
Kolesnick, R. N., Go�i, F. M., & Alonso, A. (2000) · Journal of Cellular Physiology · doi:10.1002/1097-4652(200009)184:3<285::aid-jcp2>3.0.co;2-3 · Cited by 431
Biophysical properties of lipids and dynamic membranes
Janmey, P. A., & Kinnunen, P. K. J. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.08.009 · Cited by 430
Ceramide Selectively Displaces Cholesterol from Ordered Lipid Domains (Rafts)
Megha, & London, E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309992200 · Cited by 429
Mechanisms and strategies to overcome multiple drug resistance in cancer
Ozben, T. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.02.020 · Cited by 406
The therapeutic potential of modulating the ceramide/sphingomyelin pathway
Kolesnick, R. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16127 · Cited by 393
Photosensitized labeling of a functional multidrug transporter in living drug-resistant tumor cells.
Raviv, Y., Pollard, H. B., Bruggemann, E. P., Pastan, I., & Gottesman, M. M. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39690-5 · Cited by 387
Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient
Mayer, L. D., Bally, M. B., & Cullis, P. R. (1986) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(86)90105-7 · Cited by 379
Cell biological mechanisms of multidrug resistance in tumors.
Simon, S. M., & Schindler, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3497 · Cited by 369
Lipid polymorphism and the roles of lipids in membranes
Cullis, P. R., Hope, M. J., & Tilcock, C. P. S. (1986) · Chemistry and Physics of Lipids · doi:10.1016/0009-3084(86)90067-8 · Cited by 363
The therapeutic potential of modulating the ceramide/sphingomyelin pathway
Kolesnick, R. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216127 · Cited by 351
Nanotechnology applied to overcome tumor drug resistance
Gao, Z., Zhang, L., & Sun, Y. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.05.051 · Cited by 303
Lipid Polymorphism:The Molecular Basis of Nonbilayer Phases
Gruner, S. M., Cullis, P. R., Hope, M. J., & Tilcock, C. P. S. (1985) · Annual Review of Biophysics and Biophysical Chemistry · doi:10.1146/annurev.bb.14.060185.001235 · Cited by 296
Wu, H., Hait, W. N., & Yang, J. (2003) · PubMed · Cited by 289
Slotte, J. P., & Bierman, E. L. (1988) · Biochemical Journal · doi:10.1042/bj2500653 · Cited by 288
Membrane Transporters and Channels
Huang, Y., Anderle, P., Bussey, K. J., Barbacioru, C., Shankavaram, U., Dai, Z., Reinhold, W. C., Papp, A., Weinstein, J. N., & Sadée, W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3884 · Cited by 285
Intracellular pH and the control of multidrug resistance.
Simon, S., Roy, D., & Schindler, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.3.1128 · Cited by 276
Salt screening and specific ion adsorption determine neutral-lipid membrane interactions
Petrache, H. I., Zemb, T., Belloni, L., & Parsegian, V. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509967103 · Cited by 273
Liu, Y.-Y., Han, T.-Y., Giuliano, A. E., & Cabot, M. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.2.1140 · Cited by 269
Tumor Acidity, Chemoresistance and Proton Pump Inhibitors
De Milito, A., & Fais, S. (2005) · Future Oncology · doi:10.2217/14796694.1.6.779 · Cited by 265
Metallofullerene nanoparticles circumvent tumor resistance to cisplatin by reactivating endocytosis
Liang, X.-J., Meng, H., Wang, Y., He, H., Meng, J., Lu, J., Wang, P. C., Zhao, Y., Gao, X., Sun, B., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909707107 · Cited by 256
Pan, L., Liu, J., He, Q., Wang, L., & Shi, J. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.12.040 · Cited by 252
Role of Membrane Organization and Membrane Domains in Endocytic Lipid Trafficking
Mukherjee, S., & Maxfield, F. R. (2000) · Traffic · doi:10.1034/j.1600-0854.2000.010302.x · Cited by 250
Lefranc, F., Facchini, V., & Kiss, R. (2007) · The Oncologist · doi:10.1634/theoncologist.12-12-1395 · Cited by 237
Veiga, M. P., Arrondo, J. L. R., Goñi, F. M., & Alonso, A. (1999) · Biophysical Journal · doi:10.1016/s0006-3495(99)77201-2 · Cited by 236
Romsicki, Y., & Sharom, F. J. (1999) · Biochemistry · doi:10.1021/bi990064q · Cited by 235
Vigh, L., Escribá, P. V., Sonnleitner, A., Sonnleitner, M., Piotto, S., Maresca, B., Horváth, I., & Harwood, J. L. (2005) · Progress in Lipid Research · doi:10.1016/j.plipres.2005.08.001 · Cited by 230
Lipid Polymorphisms and Membrane Shape
Frolov, V. A., Shnyrova, A. V., & Zimmerberg, J. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004747 · Cited by 225
The power of the pump: Mechanisms of action of P-glycoprotein (ABCB1)
Ambudkar, S. V., Kim, I.-W., & Sauna, Z. E. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.10.010 · Cited by 217
Lipids as a Target for Drugs Modulating Multidrug Resistance of Cancer Cells
Hendrich, A., & Michalak, K. (2003) · Current Drug Targets · doi:10.2174/1389450033347172 · Cited by 205
Anti-Apoptotic Mechanisms of Drug Resistance in Cancer
Wilson, T., Johnston, P., & Longley, D. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909788166547 · Cited by 203
Garrigues, A., Escargueil, A. E., & Orlowski, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162366399 · Cited by 201
Ferté, J. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01046.x · Cited by 194
Adhesion and Wrapping in Colloid−Vesicle Complexes
Deserno, M., & Gelbart, W. M. (2002) · The Journal of Physical Chemistry B · doi:10.1021/jp0138476 · Cited by 194
The effects of lipids and detergents on ATPase-active P-glycoprotein
Doige, C. A., Yu, X., & Sharom, F. J. (1993) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(93)90339-2 · Cited by 188
Lo, P.-K., & Sukumar, S. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.12.1879 · Cited by 184
Ewers, H., & Helenius, A. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004721 · Cited by 173
Peetla, C., Bhave, R., Vijayaraghavalu, S., Stine, A., Kooijman, E., & Labhasetwar, V. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100308n · Cited by 162
Self-citationBatrakova, E. V., Li, S., Brynskikh, A. M., Sharma, A. K., Li, Y., Boska, M. D., Gong, N., Mosley, R. L., Alakhov, V. Y., Gendelman, H. E., et al. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.004 · Cited by 159
Gouazé, V., Liu, Y.-Y., Prickett, C. S., Yu, J. Y., Giuliano, A. E., & Cabot, M. C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2329 · Cited by 158
Targeting apoptosis as an approach for gastrointestinal cancer therapy
Qiao, L., & Yu, W. B. C. (2009) · Drug Resistance Updates · doi:10.1016/j.drup.2009.02.002 · Cited by 154
Gouazé‐Andersson, V., Mirault, M.-É., Carpentier, S., Salvayre, R., Levade, T., & Andrieu‐Abadie, N. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12610-7 · Cited by 153
Wang, T., & Silvius, J. R. (2000) · Biophysical Journal · doi:10.1016/s0006-3495(00)76399-5 · Cited by 140
Jin, Y., Xu, G., YAO, Y., Li, Jin, Y., & Ying, J. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s32188 · Cited by 139
Peetla, C., & Labhasetwar, V. D. (2009) · Langmuir · doi:10.1021/la803361y · Cited by 133
Self-citationEffect of pH on the Interfacial Tension of Lipid Bilayer Membrane
Petelska, A. D., & Figaszewski, Z. A. (2000) · Biophysical Journal · doi:10.1016/s0006-3495(00)76638-0 · Cited by 133
Negatively charged phospholipids and their position in the cholesterol affinity sequence
van Dijck, P. W. M. (1979) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(79)90074-9 · Cited by 133
Milane, L. S., Ganesh, S., Shah, S., Duan, Z., & Amiji, M. M. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.03.032 · Cited by 128
Raghunand, N., Martı́nez–Zaguilán, R., Wright, S. H., & Gillies, R. J. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00021-0 · Cited by 127
Milane, L. S., Duan, Z., & Amiji, M. M. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2010.12.009 · Cited by 119
Eckford, P. D. W., & Sharom, F. J. (2008) · Biochemistry · doi:10.1021/bi801409r · Cited by 115
Hao, M., Mukherjee, S., Sun, Y., & Maxfield, F. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309793200 · Cited by 110
Plasma membrane lipid structural order in doxorubicin-sensitive and -resistant P388 cells.
Ramu, A., Glaubiger, D. L., MAGRATH, I. T., & Joshi, A. (1983) · PubMed · Cited by 108
Cellular resistance to topoisomerase-targeted drugs: from drug uptake to cell death
Larsen, A. K., & Składanowski, A. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00140-7 · Cited by 105
Callaghan, R., Berridge, G., Ferry, D., & Higgins, C. F. (1997) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(97)00079-5 · Cited by 102
Vilmar, A. C., & Sørensen, J. B. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2008.08.006 · Cited by 101
Yagüe, E., Higgins, C. F., & Raguz, S. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302269 · Cited by 94
Reduced endocytosis and altered lysosome function in cisplatin-resistant cell lines
Chauhan, S. S., Liang, X., Su, A. W., Panandiker, A. S. P., Shen, D. W., Hanover, J. A., & Gottesman, M. M. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600861 · Cited by 90
Vijayaraghavalu, S., Dermawan, J. K. T. K., Cheriyath, V., & Labhasetwar, V. D. (2012) · Molecular Pharmaceutics · doi:10.1021/mp3004622 · Cited by 86
Self-citationVijayaraghavalu, S., Peetla, C., Lu, S., & Labhasetwar, V. D. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300281t · Cited by 85
Self-citationCallaghan, R., Stafford, A. R., & Epand, R. M. (1993) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(93)90217-d · Cited by 85
Emerging roles of lipids in BCL-2 family-regulated apoptosis
Zhang, T., & Saghatelian, A. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.03.001 · Cited by 80
Endocytic Trafficking of Sphingomyelin Depends on Its Acyl Chain Length
Koivusalo, M., Jansen, M., Somerharju, P. J., & Ikonen, E. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-04-0330 · Cited by 77
Clay, A. T., & Sharom, F. J. (2012) · Biochemistry · doi:10.1021/bi301532c · Cited by 76
P53 and its molecular basis to chemoresistance in breast cancer
Knappskog, S., & Lønning, P. E. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.640322 · Cited by 74
May, G. L., Wright, L. C., Dyne, M., Mackinnon, W. B., Fox, R. M., & Mountford, C. E. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910420517 · Cited by 72
Comparative epigenomics of human and mouse mammary tumors
Demircan, B., Dyer, L. M., Gerace, M., Lobenhofer, E. K., Robertson, K. D., & Brown, K. D. (2008) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20620 · Cited by 65
Overcoming cellular multidrug resistance using classical nanomedicine formulations
Kunjachan, S., Błauż, A., Möckel, D., Theek, B., Kiessling, F. M., Etrych, T., Ulbrich, K., van Bloois, L., Storm, G., Bartosz, G., et al. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.08.028 · Cited by 64
Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer
Yandım, M. K., Apohan, E., & Baran, Y. (2012) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-012-1984-x · Cited by 63
Multifactorial nature of tumor drug resistance.
Solyanik, G. I. (2010) · PubMed · Cited by 60
Endocytic Recycling Compartments Altered in Cisplatin-Resistant Cancer Cells
Liang, X., Mukherjee, S., Shen, D., Maxfield, F. R., & Gottesman, M. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3436 · Cited by 60
Nanomedicine Against Multidrug Resistance in Cancer Treatment
Gao, J., Feng, S., & Guo, Y. (2012) · Nanomedicine · doi:10.2217/nnm.12.11 · Cited by 52
Schuldes, H., Dolderer, J. H., Zimmer, G., Knobloch, J., Bickeböller, R., Jonas, D., & Woodcock, B. G. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00450-0 · Cited by 50
Shen, D.-W., Su, A., Liang, X.-J., Panandiker, A. S. P., & Gottesman, M. M. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601956 · Cited by 49
Meschini, S., Molinari, A., Calcabrini, A., Citro, G., & Arancia, G. (1994) · Journal of Microscopy · doi:10.1111/j.1365-2818.1994.tb03516.x · Cited by 49
Fine, M., Llaguno, M. C., Lariccia, V., Lin, M.-J., Yaradanakul, A., & Hilgemann, D. W. (2011) · The Journal of General Physiology · doi:10.1085/jgp.2010104691376c · Cited by 47
Peetla, C., Rao, K. S., & Labhasetwar, V. D. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900011h · Cited by 44
Self-citationHilgemann, D. W., & Fine, M. (2011) · The Journal of General Physiology · doi:10.1085/jgp.201010470 · Cited by 44
Rauch, C. (2009) · European Biophysics Journal · doi:10.1007/s00249-009-0429-x · Cited by 43
Surface activity, lipid profiles and their implications in cervical cancer.
Banerjee, R., Preetha, A., & Huilgol, N. (2005) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.19600 · Cited by 41
Wu, F., Shao, Z.-Y., Zhai, B.-J., Zhao, C., & Shen, D.-M. (2010) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2010.10.009 · Cited by 38
Sharma, B., Peetla, C., Adjei, I. M., & Labhasetwar, V. D. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.03.011 · Cited by 31
Self-citationP-Glycoprotein in Proteoliposomes with Low Residual Detergent: The Effects of Cholesterol
Bucher, K., Belli, S., Wunderli‐Allenspach, H., & Krämer, S. D. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9326-0 · Cited by 30
Lu, S., & Labhasetwar, V. D. (2012) · Drug Delivery and Translational Research · doi:10.1007/s13346-012-0113-z · Cited by 29
Self-citationGalmarini, C. M., Warren, G., Senanayake, M. T., & Vinogradov, S. V. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.05.028 · Cited by 28
Ramu, A., Ramu, N., & Rosário, L. M. (1991) · Biochemical Pharmacology · doi:10.1016/0006-2952(91)90561-i · Cited by 26
Victorov, A. V., Janes, N., Taraschi, T. F., & Hoek, J. B. (1997) · Biophysical Journal · doi:10.1016/s0006-3495(97)78902-1 · Cited by 19
Dolderer, J. H., Zimmer, G., Woodcock, B. G., Bockhorn, H., Bickeböller, R., & Schuldes, H. (2000) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp38196 · Cited by 15
Dynamic surface tensiometry of tissues using Langmuir films
Preetha, A., Banerjee, R., & Huilgol, N. (2004) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2004.10.006 · Cited by 10
Cited by
Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy
Yong, T., Zhang, X., Bie, N., Zhang, H., Zhang, X., Li, F., Hakeem, A., Hu, J., Gan, L., Santos, H. A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11718-4 · Cited by 806
The multi-factorial nature of clinical multidrug resistance in cancer
Assaraf, Y. G., Brozovic, A., Gonçalves, A. C., Jurkovicova, D., Linē, A., Machuqueiro, M., Saponara, S., Sarmento-Ribeiro, A. B., Xavier, C. P. R., & Vasconcelos, M. H. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.100645 · Cited by 528
Lipid composition of the cancer cell membrane
Szlasa, W., Zendran, I., Zalesińska, A., Tarek, M., & Kulbacka, J. (2020) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-020-09846-4 · Cited by 435
Cell membrane modulation as adjuvant in cancer therapy
Zalba, S., & ten Hagen, T. L. M. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.10.008 · Cited by 365
Understanding and targeting resistance mechanisms in cancer
Lei, Z., Tian, Q., Teng, Q., Wurpel, J. N. D., Zeng, L., Pan, Y., & Chen, Z. (2023) · MedComm · doi:10.1002/mco2.265 · Cited by 347
Metadata
- Authors
- Peetla, C., Vijayaraghavalu, S., & Labhasetwar, V.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2013-11
- Volume
- 65
- Issue
- 13-14
- Pages
- 1686-1698
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2082272203
- Cited by
- 289
- References
- 112
- FWCI
- 1.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.